Fecal Biomarker Study for Patients With Ulcerative Colitis

Warner Chilcott

Status: Completed

Conditions: Ulcerative Colitis

Study type: Observational

Funder types: Industry

Identifiers

NCT00780507

2007096

Details and patient eligibility

About

The present study will analyze fecal levels of FC and FL in UC patients who relapse (flare) while on a QD or a BID Asacol treatment regimen and compare those levels to levels of FC and FL in UC patients who do not relapse (flare).

Enrollment: 89 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Be willing and able to provide written informed consent for this biomarker study;
• Be enrolled in Study 2007021 (QDIEM).

Exclusion criteria

• Meet the QDIEM Protocol 2007021 for Exclusion Criteria

Trial design

89 participants in 2 patient groups

1

Description:

Patients are in a state of remission

2

Description:

Patients are in a flare